Category Archives: Peptides

CJC-1295 DAC vs CJC-1295 without DAC: research comparison of half-life, GH pulse patterns, IGF-1 elevation, and lab applications.

Prof. Vladimir Khavinson’s bioregulator peptides — Epitalon, Pinealon, Prostamax, and a family of other short-chain compounds — represent four decades of Russian geroscience that Western researchers are now engaging with seriously. This guide covers the tetrapeptide/tripeptide framework, telomere research, neuroprotection findings, and the real limitations of the current evidence base.

Ipamorelin, GHRP-2, and GHRP-6 are three of the most studied growth hormone secretagogues in peptide research. This comparison breaks down their mechanisms, selectivity profiles, and distinct research applications to help investigators understand what each compound brings to the table.

In 2026, four compounds — AOD 9604, Semaglutide, Retatrutide, and 5-Amino-1MQ — have become the go-to tools for investigating how the body stores and burns fat. They work through completely different mechanisms, and knowing when to reach for each one can define whether a research protocol gets clean, interpretable results.

A research guide on PT-141 (Bremelanotide), covering MC1R–MC5R receptor system overview, hypothalamic-limbic circuit activation, and 2026 melanocortin research landscape.

A research profile of Dihexa (PNB0408), exploring its HGF/MET receptor axis, synaptogenesis promotion, cognitive rodent model data, and neuroprotective mechanisms.

An evidence-based comparison of the top 10 longevity peptides for anti-aging research in 2026, including Epitalon, BPC-157, GHK-Cu, Humanin, SS-31, MOTS-c, and more.

CagriSema’s dual-agonist profile combining cagrilintide (amylin analog) and semaglutide (GLP-1 agonist), covering OASIS Phase 3 data and comparative research versus tirzepatide.

An in-depth research guide exploring BPC-157 and TB-500 peptide stacking synergies, combination study design, and mechanistic overlap in tissue repair and regenerative research models.